SolveBio is a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises. The company works with diagnostic and R&D labs to massively scale their precision medicine offering. Screening, Rare Disease, and Oncology genetics requires accurate and fast assessment of variants. The SolveBio Genome Intelligence Service combines SolveBio’s proprietary data harmonization engine with a global network of trained genomics experts to deliver high-throughput, transparent, and reproducible DNA variant interpretation. SolveBio curation is scalable and available on-demand, allowing companies and labs to scale variant assessment as their test volume grows.
Type
Private
HQ
New York, US
Founded
2013
Size (employees)
11 (est)-8%
SolveBio was founded in 2013 and is headquartered in New York, US
Report incorrect company information

Key People/Management at SolveBio

Mark Kaganovich

Mark Kaganovich

Founder
David Caplan

David Caplan

Co-Founder
Show more

SolveBio Office Locations

SolveBio has an office in New York
New York, US (HQ)
194 Mercer Street 627 Broadway
Show all (1)
Report incorrect company information

SolveBio Financials and Metrics

Summary Metrics

Founding Date

2013

SolveBio total Funding

$2 m

Time since last funding

3 years ago

SolveBio investors

Show all financial metrics
Report incorrect company information

SolveBio Online and Social Media Presence

Embed Graph
Report incorrect company information

SolveBio Company Life and Culture

Report incorrect company information